Market Place
Sourcing Support
Azitra to Present at BIO-Europe 2024
29 Oct 2024 //
BUSINESSWIRE
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
11 Oct 2024 //
BUSINESSWIRE
Azitra Presents at European Dermatology and Venereology Congress
24 Sep 2024 //
BUSINESSWIRE
Azitra Receives Fast Track For ATR-04 Skin Rash Treatment
18 Sep 2024 //
BUSINESSWIRE
Azitra Doses First Patient In Phase 1b Trial Of ATR-12
28 Aug 2024 //
BUSINESSWIRE
Azitra Receives FDA Study May Proceed Letter For EGFR Rash IND
22 Aug 2024 //
BUSINESSWIRE
Azitra Screens First Patient For ATR-12 Phase 1b Netherton Syndrome Trial
20 Aug 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
12 Aug 2024 //
BUSINESSWIRE
Azitra Closes 10M USD Public Offering
25 Jul 2024 //
BUSINESSWIRE
Azitra Strengthens Global IP Portfolio With New Patents
23 Jul 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering
23 Jul 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Reverse Stock Split
27 Jun 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
31 May 2024 //
BUSINESSWIRE
Azitra Presents Positive ATR-04 Preclinical Data At SID
17 May 2024 //
BUSINESSWIRE
Azitra ATR-12 Netherton Data, Design At ASGCT 2024
10 May 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
09 May 2024 //
BUSINESSWIRE
Azitra`s Preclinical Data At ASGCT Gene Therapy Meeting
22 Apr 2024 //
BUSINESSWIRE
Azitra to present new data at 3 conferences in May 2024
18 Apr 2024 //
BUSINESSWIRE
Azitra Announces Full Year 2023 Financial Results and Provides Business Updates
15 Mar 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Closing of Public Offering
16 Feb 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Pricing of Public Offering
13 Feb 2024 //
BUSINESSWIRE
Azitra, Inc. Strengthens Intellectual Property Portfolio
16 Jan 2024 //
BUSINESSWIRE
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024
03 Jan 2024 //
BUSINESSWIRE
Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates
14 Nov 2023 //
BUSINESSWIRE
Azitra to Present at the H.C. Wainwright 25th Annual Global Conference
29 Aug 2023 //
PR NEWSWIRE
Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Board of Directors
19 Jul 2023 //
PR NEWSWIRE
Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer
11 Jul 2023 //
PR NEWSWIRE
Azitra, Inc. Announces Closing of Initial Public Offering
22 Jun 2023 //
PR NEWSWIRE
Bayer-partnered Azitra will use $7.5M IPO to move into clinic
22 Jun 2023 //
FIERCE BIOTECH
Azitra, Inc. Announces Closing of Initial Public Offering
21 Jun 2023 //
PR NEWSWIRE
Azitra, Inc. Announces Pricing of Initial Public Offering
15 Jun 2023 //
PR NEWSWIRE
A small Connecticut biotech throws hat into IPO ring
21 Feb 2023 //
ENDPTS
Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Strains
07 Jul 2020 //
BIOSPACE
Azitra Announces Rare Pediatric Disease Designation for ATR-12
27 May 2020 //
BUSINESSWIRE
Bayer, Azitra ink joint development pact to identify & characterise skin
13 Jan 2020 //
PHARMABIZ
Bayer and Azitra Partner to Harness the Human Skin Microbiome
11 Jan 2020 //
BUSINESS WIRE
Azitra Completes $14 Million Series A Financing
16 Oct 2019 //
BUSINESSWIRE
